Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery

被引:4
|
作者
Ma, Guanchen [1 ,2 ]
Zeng, Shaoqing [1 ,2 ]
Zhao, Yingjun [1 ,2 ]
Chi, Jianhua [1 ,2 ]
Wang, Li [3 ]
Li, Qingshui [4 ]
Wang, Jing [5 ]
Yao, Shuzhong [6 ]
Zhou, Qi [7 ]
Chen, Youguo [8 ]
Jiao, Xiaofei [1 ,2 ]
Liu, Xingyu [1 ,2 ]
Yu, Yang [1 ,2 ]
Huo, Yabing [1 ,2 ]
Li, Ming [1 ,2 ]
Peng, Zikun [1 ,2 ]
Ma, Ding [1 ,2 ]
Hu, Ting [1 ,2 ]
Gao, Qinglei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gynecol Oncol, 1095 Jiefang Ave, Wuhan 430000, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Key Lab Minist Educ,Canc Biol Res Ctr,Natl Clin Re, Wuhan, Peoples R China
[3] Zhengzhou Univ, Canc Hosp, Henan Tumor Hosp, Dept Gynecol, Zhengzhou, Peoples R China
[4] Shandong Canc Hosp & Inst, Dept Gynecol Oncol, Jinan, Shandong, Peoples R China
[5] Cent South Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Xiangya Sch Med, Changsha, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 58,2nd Zhongshan Rd, Guangzhou 510080, Peoples R China
[7] Chongqing Canc Hosp, Dept Gynecol Oncol, Chongqing 400030, Peoples R China
[8] Soochow Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Suzhou 215123, Peoples R China
基金
美国国家科学基金会;
关键词
Mucinous ovarian cancer; Nomogram; Cancer-specific survival; SEER database; RESIDUAL DISEASE;
D O I
10.1186/s13048-023-01213-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BackgroundMucinous epithelial ovarian cancer (mEOC) is a relatively uncommon subtype of ovarian cancer with special prognostic features, but there is insufficient research in this area. This study aimed to develop a nomogram for the cancer-specific survival (CSS) of mEOC based on Surveillance, Epidemiology, and End Results (SEER) database and externally validate it in National Union of Real World Gynecological Oncology Research and Patient Management (NUWA) platform from China.MethodsPatients screened from SEER database were allocated into training and internal validation cohort in a ratio of 7: 3, with those from NUWA platform as an external validation cohort. Significant factors selected by Cox proportional hazard regression were applied to establish a nomogram for 3-year and 5-year CSS. The performance of nomogram was assessed by concordance index, calibration curves and Kaplan-Meier (K-M) curves.ResultsThe training cohort (n = 572) and internal validation cohort (n = 246) were filtered out from SEER database. The external validation cohort contained 186 patients. Baseline age, tumor stage, histopathological grade, lymph node metastasis and residual disease after primary surgery were significant risk factors (p < 0.05) and were included to develop the nomogram. The C-index of nomogram in training, internal validation and external validation cohort were 0.869 (95% confidence interval [CI], 0.838-0.900), 0.839 (95% CI, 0.787-0.891) and 0.800 (95% CI, 0.738-0.862), respectively. The calibration curves of 3-year and 5-year CSS in each cohort showed favorable agreement between prediction and observation. K-M curves of different risk groups displayed great discrimination.ConclusionThe discrimination and goodness of fit of the nomogram indicated its satisfactory predictive value for the CSS of mEOC in SEER database and external validation in China, which implies its potential application in different populations.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC)
    Cheng, X.
    Jiang, R.
    Li, Z. T.
    Tang, J.
    Cai, S. M.
    Zhang, Z. Y.
    Tian, W. J.
    Zang, R. Y.
    EJSO, 2009, 35 (10): : 1105 - 1108
  • [32] Development and External Validation of a Nomogram to Predict Cancer-Specific Survival in Patients with Primary Intestinal Non-Hodgkin Lymphomas
    Zhang, Cuifen
    Liu, Zeyu
    Tao, Jiahao
    Lin, Lizhu
    Zhai, Linzhu
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 9271 - 9285
  • [33] Development and Validation of a Prognostic Nomogram to Predict Cancer-Specific Survival in Adult Patients With Pineoblastoma (vol 10, 1021, 2020)
    Jing, Yajun
    Deng, Wenshuai
    Zhang, Huawei
    Jiang, Yunxia
    Dong, Zuoxiang
    Fan, Fan
    Sun, Peng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Development and validation of a prognostic nomogram for predicting cancer-specific survival in advanced endometrial carcinoma after surgery: a retrospective analysis of the SEER Database
    Zheng, Chunqin
    Chen, Weiqiang
    Zheng, Zhixiang
    Liang, Xiaoling
    Xu, Xiuxia
    Fang, Danmei
    Ma, Ruijun
    Fan, Fufang
    Ni, Yanhong
    Zhang, Peili
    Wu, Xuanhua
    BMJ OPEN, 2023, 13 (09):
  • [35] Construction and validation of a prognostic nomogram for predicting cancer-specific survival in patients with intermediate and advanced colon cancer after receiving surgery and chemotherapy
    Shi, Yiheng
    Wu, Xiaoting
    Qu, Wanxi
    Tian, Jiahao
    Pang, Xunlei
    Fan, Haohan
    Fei, Sujuan
    Miao, Bei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (14) : 12821 - 12834
  • [36] Construction and validation of a prognostic nomogram for predicting cancer-specific survival in patients with intermediate and advanced colon cancer after receiving surgery and chemotherapy
    Yiheng Shi
    Xiaoting Wu
    Wanxi Qu
    Jiahao Tian
    Xunlei Pang
    Haohan Fan
    Sujuan Fei
    Bei Miao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 12821 - 12834
  • [37] Development and Validation of Nomograms to Predict Overall Survival Outcomes in Serous Ovarian Cancer Patients with Satisfactory Cytoreductive Surgery and Chemotherapy
    Liu, Yuan-Yuan
    Zhao, Ren-Feng
    Liu, Chao
    Zhou, Jie
    Yang, Liu
    Li, Li
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 123 - 131
  • [38] Development and internal validation of a prognostic model for survival after debulking surgery for epithelial ovarian cancer
    Rutten, M. J.
    Boldingh, J. H. L.
    Schuit, E.
    Trum, H.
    van Driel, W.
    Mol, B. W. J.
    Kenter, G. G.
    Buist, M. R.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (01) : 13 - 18
  • [39] A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation study
    Xie, Liangyun
    Zhang, Yafei
    Niu, Xiedong
    Jiang, Xiaomei
    Kang, Yuan
    Diao, Xinyue
    Fang, Jinhai
    Yu, Yilin
    Yao, Jun
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [40] Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer
    Zang, RY
    Zhang, ZY
    Li, ZT
    Chen, J
    Tang, MQ
    Liu, Q
    Cai, SM
    JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (01) : 24 - 30